Copyright
©The Author(s) 2022.
World J Clin Oncol. Jul 24, 2022; 13(7): 652-662
Published online Jul 24, 2022. doi: 10.5306/wjco.v13.i7.652
Published online Jul 24, 2022. doi: 10.5306/wjco.v13.i7.652
Table 2 Acute gastrointestinal and genitourinary toxicity (Radiation Therapy Oncology Group/European Organization for Research and Treatment of Cancer criteria) according to total radiotherapy dose to the surgical bed
| Total dose | |||||||||
| 66-68 Gy (n = 54) | 70 Gy (n = 86) | 72 Gy (n = 36) | |||||||
| Grade (G) | GI | GII | GIII | GI | GII | GIII | GI | GII | GIII |
| Acute GU toxicity | 11 (20.4%) | 2 (3.7%) | 0 | 17 (19.8%) | 4 (4.7%) | 0 | 3 (8.3%) | 2 (5.6%) | 1 (2.8%) |
| Acute GI toxicity | 16 (29.6%) | 2 (3.7%) | 0 | 23 (26.7%) | 6 (6.9%) | 0 | 2 (5.6%) | 1 (2.8%) | 0 |
- Citation: Hervás-Morón A, Domínguez-Rullán J, Santana VD, Valero M, Vallejo C, Sancho S, Fuentes JDG, Cámara Gallego M, López-Campos F. Assessing radiation dose for postoperative radiotherapy in prostate cancer: Real world data. World J Clin Oncol 2022; 13(7): 652-662
- URL: https://www.wjgnet.com/2218-4333/full/v13/i7/652.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i7.652